Topoisomerase inhibitor4 (compound 45) is a dual Topo I/II inhibitor that induces G2/M phase arrest and apoptosis, demonstrating potent antitumor activity. It is a valuable research tool for investigating DNA damage response mechanisms and evaluating anticancer efficacy in both cellular and animal model studies.